Head and neck cancer drug
Clinical update Previous     Next

Head and neck cancer drug

Lynne Pearce Freelance health writer

Essential facts

Nivolumab is an immunotherapy drug and belongs to a group of drugs called monoclonal antibodies. It is used in the treatment of several cancers, including advanced melanoma, advanced non-small cell lung cancer and advanced renal cell carcinoma. It is also used in clinical trials for other types of cancer.

Cancer Nursing Practice. 16, 10,11-11. doi: 10.7748/cnp.16.10.11.s9

You need a subscription to read the full article